Genetic Technologies lower following resignation of CEO

Genetic Technologies (GENE), a life sciences company based in Australia that is listed for trading in the U.S., announced that following its annual general meeting two directors will be leaving the board and another has resigned effective immediately. Also, the company's CEO, Dr. Paul MacLeman, and the company's VP Legal and Corporate Development resigned following the meeting, the company announced. In early morning trading, shares trading in New York fell 12c, or 4.46%, to $2.57.

View Comments (0)